"Myasthenia Gravis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed against acetylcholine receptors damage the motor endplate portion of the NEUROMUSCULAR JUNCTION, impairing the transmission of impulses to skeletal muscles. Clinical manifestations may include diplopia, ptosis, and weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles. THYMOMA is commonly associated with this condition. (Adams et al., Principles of Neurology, 6th ed, p1459)
| Descriptor ID |
D009157
|
| MeSH Number(s) |
C10.114.656 C10.668.758.725 C20.111.258.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myasthenia Gravis".
Below are MeSH descriptors whose meaning is more specific than "Myasthenia Gravis".
This graph shows the total number of publications written about "Myasthenia Gravis" by people in this website by year, and whether "Myasthenia Gravis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 8 | 2 | 10 |
| 2018 | 10 | 0 | 10 |
| 2019 | 4 | 1 | 5 |
| 2020 | 6 | 0 | 6 |
| 2021 | 5 | 1 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Myasthenia Gravis" by people in Profiles.
-
Neuromuscular complications of coronavirus disease-19. Curr Opin Neurol. 2021 10 01; 34(5):669-674.
-
Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection. Eur J Neurol. 2021 Oct; 28(10):3537-3539.
-
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic. Neurol Sci. 2021 Dec; 42(12):4889-4892.
-
Transient acetylcholine receptor-related myasthenia gravis, post multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19 infection. BMJ Case Rep. 2021 Aug 11; 14(8).
-
COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study. Neurol Neurochir Pol. 2022; 56(1):61-67.
-
Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases. Clin Neurol Neurosurg. 2021 Sep; 208:106834.
-
Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental? BMJ Case Rep. 2021 Jul 21; 14(7).
-
Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report. Ann Rheum Dis. 2021 10; 80(10):1359-1361.
-
Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE). Muscle Nerve. 2021 09; 64(3):270-276.
-
COVID-19 and Myositis: What We Know So Far. Curr Rheumatol Rep. 2021 07 03; 23(8):63.